These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 15471827

  • 1. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
    Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, Israel O.
    J Nucl Med; 2004 Oct; 45(10):1640-6. PubMed ID: 15471827
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.
    Chung HH, Jo H, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB, Lee HP.
    Gynecol Oncol; 2007 Mar; 104(3):529-34. PubMed ID: 17049971
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Mar; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
    Jiménez-Bonilla JF, Quirce R, Martínez-Rodríguez I, Banzo I, Rubio-Vassallo AS, Del Castillo-Matos R, Ortega-Nava F, Martínez-Amador N, Ibáñez-Bravo S, Carril JM.
    Lung Cancer; 2013 Jul; 81(1):71-6. PubMed ID: 23597930
    [Abstract] [Full Text] [Related]

  • 7. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
    Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, Fukuda H.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
    [Abstract] [Full Text] [Related]

  • 8. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.
    Hellwig D, Gröschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM.
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):13-21. PubMed ID: 16151765
    [Abstract] [Full Text] [Related]

  • 10. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
    Toba H, Sakiyama S, Otsuka H, Kawakami Y, Takizawa H, Kenzaki K, Kondo K, Tangoku A.
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804
    [Abstract] [Full Text] [Related]

  • 11. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H, Henderson RW, Conti PS.
    J Comput Assist Tomogr; 2007 Nov; 31(2):223-8. PubMed ID: 17414758
    [Abstract] [Full Text] [Related]

  • 12. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
    Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O.
    J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408
    [Abstract] [Full Text] [Related]

  • 13. The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.
    Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, Ball DL.
    J Nucl Med; 2001 Nov; 42(11):1605-13. PubMed ID: 11696628
    [Abstract] [Full Text] [Related]

  • 14. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1432-41. PubMed ID: 16125870
    [Abstract] [Full Text] [Related]

  • 15. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
    Thrall MM, DeLoia JA, Gallion H, Avril N.
    Gynecol Oncol; 2007 Apr 01; 105(1):17-22. PubMed ID: 17208284
    [Abstract] [Full Text] [Related]

  • 16. The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.
    Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB.
    Eur J Nucl Med Mol Imaging; 2008 Jun 01; 35(6):1081-8. PubMed ID: 18180917
    [Abstract] [Full Text] [Related]

  • 17. Detecting recurrence of gastric cancer: the value of FDG PET/CT.
    Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT.
    Abdom Imaging; 2009 Jul 01; 34(4):441-7. PubMed ID: 18543017
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
    Ardito A, Massaglia C, Pelosi E, Zaggia B, Basile V, Brambilla R, Vigna-Taglianti F, Duregon E, Arena V, Perotti P, Penna D, Terzolo M.
    Eur J Endocrinol; 2015 Dec 01; 173(6):749-56. PubMed ID: 26346137
    [Abstract] [Full Text] [Related]

  • 19. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
    Gordin A, Golz A, Daitzchman M, Keidar Z, Bar-Shalom R, Kuten A, Israel O.
    Int J Radiat Oncol Biol Phys; 2007 Jun 01; 68(2):370-6. PubMed ID: 17324532
    [Abstract] [Full Text] [Related]

  • 20. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 01; 28(2):108-11. PubMed ID: 15854393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.